Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Keratinocyte differentiation modulator refers to a functional class of molecules rather than a single specific protein or receptor. These modulators encompass a wide range of targets, including transcription factors like P63 and ZNF750, nuclear receptors such as the Vitamin D receptor (VDR) and Retinoic Acid Receptors (RAR), and signaling proteins like those in the Notch pathway. Their primary biological role is to coordinate the complex program of gene expression that allows basal keratinocytes to exit the cell cycle and undergo terminal differentiation into the protective cornified layer of the skin. In dermatological diseases such as psoriasis and atopic dermatitis, this differentiation process is often impaired or accelerated, leading to barrier dysfunction and inflammation. Therapeutic strategies targeting these modulators aim to restore normal epidermal homeostasis and improve skin barrier integrity.
Modulation of signaling pathways (e.g., Notch, PPAR, Vitamin D receptor) or transcription factors (e.g., P63, ZNF750) that govern the transition of basal keratinocytes to terminally differentiated corneocytes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte differentiation modulator.